KZR vs REG · $53.9M cap vs P/E 34, rev $1.45B
Kezar Life Sciences Inc (KZR) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
KZR currently screens at market cap $53.9M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the KZR and REG stock pages for the full models.
Not investment advice.